{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:00:52Z","timestamp":1760266852648,"version":"3.33.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1991,11]]},"DOI":"10.1136\/ard.50.suppl_4.839","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T04:58:13Z","timestamp":1201582693000},"page":"839-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"S4","title":["Raynaud's phenomenon: its relevance to scleroderma."],"prefix":"10.1016","volume":"50","author":[{"given":"J.J","family":"Belch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","article-title":"Del 'asphyre et de la gangrene symetriques des extremites","author":"Raynaud, M.","year":"1888","unstructured":"Raynaud M. Del 'asphyre et de la gangrene symetriques des extremites. Paris, 1862. (Translated by Thomas Barlow, London: New Sydenham Society, 1888.)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0021-9681(86)90109-8","article-title":"Prevalence of Raynaud's phenomenon in the general population","volume":"39","author":"R, Maricq H.; C, Weinrich M.; E, Keil J.; E, Le Roy C.","year":"1986","unstructured":"Maricq H R, Weinrich M C, Keil J E, Le Roy C E. Prevalence of Raynaud's phenomenon in the general population. Chronic Dis 1986; 39: 423-7.","journal-title":"Chronic Dis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/00365517809104884","article-title":"Prevalence of primary Raynaud phenomena in young females","volume":"37","author":"Olsen, N.; L, Neilsen S.","year":"1978","unstructured":"Olsen N, Neilsen S L. Prevalence of primary Raynaud phenomena in young females. Scandj Clin Invest 1978; 37: 761-4.","journal-title":"Scandj Clin Invest"},{"issue":"84","key":"ref_4","first-page":"359","article-title":"Systemic scleroderma: a clinical study of 727 cases","volume":"1961","author":"L, Tuffanelli D.; K, Winkelman R.","unstructured":"Tuffanelli D L, Winkelman R K. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 1961; 84: 359-67.","journal-title":"Arch Dermatol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.30.6.581","article-title":"Survival in sckeroderma","volume":"30","author":"Bennett, R.; Bluestone, R.; L, Holt P.J.; L, Bywaters E.G.","year":"1971","unstructured":"Bennett R, Bluestone R, Holt P J L, Bywaters E G L. Survival in sckeroderma. Ann Rhewn Dis 1971; 30: 581-8.","journal-title":"Ann Rhewn Dis"},{"issue":"179","key":"ref_6","first-page":"99","article-title":"Raynaud's phenomenon","volume":"1962","author":"G, De Takats; F, Fowler E.","unstructured":"De Takats G, Fowler E F. Raynaud's phenomenon. JAMA 1962; 179: 99-106.","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/anr.1780320809","article-title":"Prevalence of scleroderma spectrum disorders in the general population _ of South-Carolina","volume":"32","author":"R, Maricq H.; C, Weinrich M.; E, Keil J.","year":"1989","unstructured":"Maricq H R, Weinrich M C, Keil J E, et al. Prevalence of scleroderma spectrum disorders in the general population _ of South-Carolina. Arthritis Rheum 1989; 32: 998-1006.","journal-title":"Arthritis Rheum"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.16.6.1012","article-title":"Hines E A Jr. Raynaud's disease among young women and girls","volume":"16","author":"W, Jr, Gifford R.","year":"1957","unstructured":"Gifford R W Jr, Hines E A Jr. Raynaud's disease among young women and girls. Circulation 1957; 16: 1012-21.","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9610(81)90272-5","article-title":"Evaluation and management of patients with Raynaud's syndrome","volume":"142","author":"M, Porter J.; P, Rivers S.; J, Anderson C.; M, Baur G.","year":"1981","unstructured":"Porter J M, Rivers S P, Anderson C J, Baur G M. Evaluation and management of patients with Raynaud's syndrome. Am Surg 1981; 142: 183-9.","journal-title":"Am Surg"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-9343(88)90109-X","article-title":"Prospective study of the evolution of Raynaud's phenomenon","volume":"84","year":"1988","unstructured":"Fitzgerald 0, Hess E, O'Connor G, Spencer-Green G. Prospective study of the evolution of Raynaud's phenomenon. Am Med 1988; 84: 718-26.","journal-title":"Am Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0049-0172(86)90043-0","article-title":"Raynaud phenomenon","volume":"16","author":"M, Campbell P.; C, LeRoy E.","year":"1986","unstructured":"Campbell P M, LeRoy E C. Raynaud phenomenon. Semin Arthritis Rheum 1986; 16: 92-106.","journal-title":"Semin Arthritis Rheum"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.","journal-title":"Arthritis Rheum"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.47.8.634","article-title":"Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting","volume":"47","author":"M, Kallenberg C.G.; A, Wouda A.; A, Hoet M.; J, Van Venrooij W.","year":"1988","unstructured":"Kallenberg C G M, Wouda A A, Hoet M A, Van Venrooij W J. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47: 634-41.","journal-title":"Ann Rheum Dis"},{"key":"ref_14","first-page":"87","article-title":"Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease","volume":"28","author":"D, Gerbracht D.; D, Steen V.","year":"1985","unstructured":"Gerbracht D D, Steen V D, Ziegler G L, Medsger Th A, Rodnan G P. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthrtis Rheum 1985; 28: 87-92.","journal-title":"Ziegler G L, Medsger Th; Arthrtis Rheum"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0889-857X(21)01038-3","article-title":"Early detection of connective tissue disease in patients with Raynaud's phenomenon","volume":"16","author":"M, Kallenberg C.G.","year":"1990","unstructured":"Kallenberg C G M. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990; 16: 11-30.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref_16","first-page":"59","article-title":"Raynaud's syndrome: diagnostic and therapeutic considerations","volume":"43","author":"I, Friedman E.","year":"1988","unstructured":"Friedman E I, Taylor L M, Porter J M. Late-onset Raynaud's syndrome: diagnostic and therapeutic considerations. Geriatrics 1988; 43: 59-70.","journal-title":"Geriatrics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3476(89)80604-3","article-title":"Raynaud's syndrome in childhood","volume":"114","author":"M, Duffy C.; M, Laxer R.; P, Lee; C, Ramsay; M, Fritzler; D, Silverman E.","year":"1989","unstructured":"Duffy C M, Laxer R M, Lee P, Ramsay C, Fritzler M, Silverman E D. Raynaud's syndrome in childhood. J Pediatr 1989; 114: 73-8.","journal-title":"J Pediatr"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(80)90417-9","article-title":"Systemic involvement and immunological findings in patients presenting with Raynaud's phenomenon","volume":"69","author":"M, Kallenberg C.G.; A, Wouda A.; H, The T.","year":"1980","unstructured":"Kallenberg C G M, Wouda A A, The T H. Systemic involvement and immunological findings in patients presenting with Raynaud's phenomenon. Am J Med 1980; 69: 675-80.","journal-title":"Am J Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0025-7125(16)30623-X","article-title":"Raynaud's phenomenon and diseases","volume":"73","author":"B, Cardelli M.; M, Kleinsmith D.","year":"1989","unstructured":"Cardelli M B, Kleinsmith D M. Raynaud's phenomenon and diseases. Med Clin North Am 1989; 73: 1127-41.","journal-title":"Med Clin North Am"},{"key":"ref_20","first-page":"33","article-title":"The spectrum of scleroderma. Hosp Pract [Off]","volume":"10","author":"C, LeRoy E.; R, Lomeo","year":"1989","unstructured":"LeRoy E C, Lomeo R. The spectrum of scleroderma. Hosp Pract [Off] 1989; 10: 33-42."},{"key":"ref_21","first-page":"151","article-title":"Raynaud's phenomenon and microvascular abnormalities in scleroderma (systemic sclerosis)","author":"R, Maricq H.","year":"1988","unstructured":"Maricq H R. Raynaud's phenomenon and microvascular abnormalities in scleroderma (systemic sclerosis). In: Jayson M I V, Black C M, eds. Systemic sclerosis: scleroderma. London: Wiley, 1988: 151-66."},{"issue":"36","key":"ref_22","first-page":"73","article-title":"Skin capillaries in scieroderma","volume":"1926","author":"E, Brown G.; A, O.'Leary P.","unstructured":"Brown G E, O'Leary P A. Skin capillaries in scieroderma. Arch Intern Med 1926; 36: 73-88.","journal-title":"Arch Intern Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02284061","article-title":"Antinuclear antibodies in scleroderma, mixed connective tissue disease and primary Raynaud's phenomenon","volume":"7","author":"Cruz, M.; Meiia, G.; Lavalle, C.; J, Cortes J.; A, Reyes P.","year":"1988","unstructured":"Cruz M, Meiia G, Lavalle C, Cortes J J, Reyes P A. Antinuclear antibodies in scleroderma, mixed connective tissue disease and primary Raynaud's phenomenon. Clin Rheumatol 1988; 7: 80-6.","journal-title":"Clin Rheumatol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/ard.48.9.771","article-title":"Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease","volume":"48","author":"A, Goldman J.","year":"1989","unstructured":"Goldman J A. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease. Ann Rheum Dis 1989; 48: 771-5.","journal-title":"Ann Rheum Dis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlation and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"D, Steen V.; L, Powell D.; A, Medsger T.","year":"1988","unstructured":"Steen V D, Powell D L, Medsger T A. Clinical correlation and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31: 196-203.","journal-title":"Arthritis Rheum"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.1780311114","article-title":"A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon","volume":"31","author":"Gabrielli, A.; Montroni, M.; Rupoli, S.; L, Caniglia M.; De Lustro, F.; Danieli, G.","year":"1988","unstructured":"Gabrielli A, Montroni M, Rupoli S, Caniglia M L, De Lustro F, Danieli G. A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon. Arthritis Rheum 1988; 31: 1432-6.","journal-title":"Arthritis Rheum"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0262-1746(85)90029-0","article-title":"Increased prostacyclin metabolitesand decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome","volume":"17","author":"F, Belch J.J.; M, McLaren; J, Anderson","year":"1985","unstructured":"Belch J J F, McLaren M, Anderson J, et al. Increased prostacyclin metabolitesand decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot Med 1985; 17: 1-9.","journal-title":"Prostaglandins Leukot Med"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/003693308703200106","article-title":"Abnormal biochemical and cellular parameters in the blood of patients with Raynaud's phenomenon","volume":"32","author":"F, Belch J.J.; J, Drury; P, Flannigan","year":"1987","unstructured":"Belch J J F, Drury J, Flannigan P, et al. Abnormal biochemical and cellular parameters in the blood of patients with Raynaud's phenomenon. Scott MedJ 1987; 32: 12-14.","journal-title":"Scott MedJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.48.7.586","article-title":"Platelet serotonin in systemic sclerosis","volume":"48","author":"S, Klimiuk P.; A, Grennan; C, Weinkove; V, Jayson M.I.","year":"1989","unstructured":"Klimiuk P S, Grennan A, Weinkove C, Jayson M I V. Platelet serotonin in systemic sclerosis. Ann Rheum Dis 1989; 48: 586-9.","journal-title":"Ann Rheum Dis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0049-3848(80)90406-5","article-title":"Plasma exchange and platelet function in Raynaud's phenomenon","volume":"19","author":"Zehavi, J.; P, Hamilton W.A.; G, O.'Reilly M.J.; Leyton, J.; T, Cotton L.; V, Kakkar V.","year":"1980","unstructured":"Zehavi J, Hamilton W A P, O'Reilly M J G, Leyton J, Cotton L T, Kakkar V V. Plasma exchange and platelet function in Raynaud's phenomenon. Thromb Res 1980; 19: 85-93.","journal-title":"Thromb Res"},{"key":"ref_31","first-page":"99","article-title":"B-thromboglobulin in the differential diagnosis of Raynaud's phenomenon","volume":"12","author":"R, Seibold J.; Plasma, Harris J.N.","year":"1985","unstructured":"Seibold J R, Harris J N. Plasma,B-thromboglobulin in the differential diagnosis of Raynaud's phenomenon. J Rheumatol 1985; 12: 99-103.","journal-title":"J Rheumatol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in sclerodermaand in Raynaud's phenomenon","volume":"94","author":"B, Kahaleh M.; I, Osborn; C, LeRoy E.","year":"1981","unstructured":"Kahaleh M B, Osborn I, LeRoy E C. Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in sclerodermaand in Raynaud's phenomenon. Ann Intern Med 1981; 94: 482-4.","journal-title":"Ann Intern Med"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00270462","article-title":"Vascular damage and factor VIII related antigen in the rheumatic diseases","volume":"7","author":"F, Belch J.J.; A, Zoma; I, Richards; D, Forbes C.; D, Sturrock R.","year":"1987","unstructured":"Belch J J F, Zoma A, Richards I, Forbes C D, Sturrock R D. Vascular damage and factor VIII related antigen in the rheumatic diseases. Rheumatol Int 1987; 7: 107-11.","journal-title":"Rheumatol Int"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ard.48.4.312","article-title":"A study of headache and migraine in Sjogren's syndrome and other rheumatic disorders","volume":"48","author":"Pal, B.; Gibson, C.; Passmore, J.; D, Griffiths I.; C, Dick W.","year":"1989","unstructured":"Pal B, Gibson C, Passmore J, Griffiths I D, Dick W C. A study of headache and migraine in Sjogren's syndrome and other rheumatic disorders. Ann Rheum Dis 1989; 48: 312-6.","journal-title":"Ann Rheum Dis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM198605293142201","article-title":"Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis","volume":"314","author":"Kahan, A.; Y, Devaux J.; Amor, B.","year":"1986","unstructured":"Kahan A, Devaux J Y, Amor B, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N EnglI Med 1986; 314: 1397-402.","journal-title":"N EnglI Med"},{"key":"ref_36","first-page":"967","article-title":"Gallium lung scans in progressive systemic sclerosis","volume":"26","author":"Baron, M.; Feiglin, D.; Hyland, R.; B, Urowitz M.; Shiff, B.","year":"1983","unstructured":"Baron M, Feiglin D, Hyland R, Urowitz M B, Shiff B. Gallium lung scans in progressive systemic sclerosis. Arthritis Rheum 1983; 26: 967-74.","journal-title":"Arthritis Rheum"},{"key":"ref_37","first-page":"426","article-title":"Decreased oesophageal blood flow in patients with Raynaud's phenomenon","volume":"27","author":"F, Belch J.J.; D, Land; R, Park R.H.; H, McKillop J.; F, McKenzie J.","year":"1988","unstructured":"Belch J J F, Land D, Park R H R, McKillop J H, McKenzie J F. Decreased oesophageal blood flow in patients with Raynaud's phenomenon. BrJ Rhewuatol 1988; 27: 426-30.","journal-title":"BrJ Rhewuatol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1084\/jem.149.6.1326","article-title":"Endothelial cell injury in scleroderma","volume":"149","author":"B, Kahaleh M.; K, Sherer G.; C, LeRoy E.","year":"1979","unstructured":"Kahaleh M B, Sherer G K, LeRoy E C. Endothelial cell injury in scleroderma. J Exp Med 1979; 149: 1326-35.","journal-title":"J Exp Med"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9610(72)90277-2","article-title":"Oxygen supply in healing tissue","volume":"123","author":"Niinikoski, J.; K, Hunt T.; E, Dunphy J.","year":"1979","unstructured":"Niinikoski J, Hunt T K, Dunphy J E. Oxygen supply in healing tissue. Am J Surg 1979; 123: 247-52.","journal-title":"Am J Surg"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02393382","article-title":"Disorders of wound healing","volume":"4","author":"K, Hunt T.","year":"1980","unstructured":"Hunt T K. Disorders of wound healing. WorldJ Surg 1980; 4: 271-7.","journal-title":"WorldJ Surg"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archderm.1988.01670090035007","article-title":"Cutaneous hypoxia in patients with systemic sclerosis","volume":"124","author":"L, Silversmith J.; D, Steen V.; A, Medsger T.; V, Falanga","year":"1988","unstructured":"Silversmith J L, Steen V D, Medsger T A, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis. Arch Dermatol 1988; 124: 1379-82.","journal-title":"Arch Dermatol"},{"key":"ref_42","first-page":"337","article-title":"The pathology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes","volume-title":"viscera. Clin Proc 1945; 4","author":"H, Goetz R.","unstructured":"Goetz R H. The pathology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in viscera. Clin Proc 1945; 4: 337-92. Raynaud's phenomenon: its relevance to sckeroderma"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","article-title":"Morphological changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon","volume":"50","author":"Rodnan G P, Myerowtz R L, Justh G 0","year":"1980","unstructured":"Rodnan G P, Myerowtz R L, Justh G 0. Morphological changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon. Medicine (Baltimore) 1980; 50: 393-408.","journal-title":"Medicine (Baltimore)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.1.6155.20-a","article-title":"Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon","author":"H, Nilsen K.","year":"1979","unstructured":"Nilsen K H. Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon. BMJ 1979; i: 20-1.","journal-title":"BMJ"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJM198304143081507","article-title":"Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon","volume":"308","author":"J, Rodeeheffer R.; A, Rommer J.; F, Wigley; R, Smith C.","year":"1983","unstructured":"Rodeeheffer R J, Rommer J A, Wigley F, Smith C R. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983; 308: 880-3.","journal-title":"N Engl J Med"},{"key":"ref_46","first-page":"18","article-title":"Nifedipine may be harmful in the treatment of Raynaud's phenomenon secondary to systemic sclerosis","volume":"28","author":"Lindsay, G.; G, McCullough R.; Seaman, J.; Hawkins, R.; Weil, J.; Steigerwald, J.","year":"1985","unstructured":"Lindsay G, McCullough R G, Seaman J, Hawkins R, Weil J, Steigerwald J. Nifedipine may be harmful in the treatment of Raynaud's phenomenon secondary to systemic sclerosis [abstract]. Arthritis Rheum 1985; 28: S18.","journal-title":"Arthritis Rheum"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/000331978904000207","article-title":"Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon","volume":"40","author":"F, Challenor V.; G, Waller D.; A, Hayward R.; J, Griffin M.; S, Roath O.","year":"1989","unstructured":"Challenor V F, Waller D G, Hayward R A, Griffin M J, Roath O S. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon. Angiology 1989; 40: 122-8.","journal-title":"Angiology"},{"key":"ref_48","first-page":"1031","article-title":"Treatment of vasospastic disease with prostaglandin El. BMJ'","volume":"281","author":"C, Clifford P.; R, Martin M.F.; F, Sheddon M.; D, Kirby J.; N, Baird R.; A, Dieppe P.","year":"1980","unstructured":"Clifford P C, Martin M F R, Sheddon M F, Kirby J D, Baird R N, Dieppe P A. Treatment of vasospastic disease with prostaglandin El. BMJ' 1980; 281: 1031-4."},{"key":"ref_49","first-page":"313","article-title":"Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome","volume":"i:","author":"F, Belch J.J.; P, Newman; K, Drury J.","year":"1981","unstructured":"Belch J J F, Newman P, Drury J K, et al. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet 1981; i: 313-5.","journal-title":"Lancet"},{"key":"ref_50","first-page":"97","article-title":"The effect of ZK36374 (iloprost) on white cell behaviour","volume-title":"its stable analogue iloprost","author":"F, Belch J.J.; R, Saniabadi A.; D, Forbes C.","year":"1986","unstructured":"Belch J J F, Saniabadi A R, Forbes C D. The effect of ZK36374 (iloprost) on white cell behaviour. In: Schror K, Gryglewski R J, eds. Prostacyclin and its stable analogue iloprost. Berlin: Springer, 1986: 97-102."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/27.3.220","article-title":"Successful treatment ofRaynaud's syndrome with iloprost, a chemically stable prostacyclin analogue","volume":"27","author":"A, Yardumian D.; A, Isenberg D.; M, Rustin","year":"1988","unstructured":"Yardumian D A, Isenberg D A, Rustin M, et al. Successful treatment ofRaynaud's syndrome with iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol 1988; 27: 220-6.","journal-title":"Br J Rheumatol"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study","volume":"298","author":"Rademaker, M.; D, Cooke E.; E, Almond N.","year":"1989","unstructured":"Rademaker M, Cooke E D, Almond N E, et al. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. BMJ 1989; 298: 561-4.","journal-title":"BMJ"},{"key":"ref_53","first-page":"1130","article-title":"Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment for Raynaud's phenomenon","volume":"ii:","author":"F, Belch J.J.; R, Madhok; B, Shaw; P, Leiberman; D, Forbes C.; D, Sturrock R.","year":"1985","unstructured":"Belch J J F, Madhok R, Shaw B, Leiberman P, Forbes C D, Sturrock R D. Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment for Raynaud's phenomenon. Lancet 1985; ii: 1130-3.","journal-title":"Lancet"},{"key":"ref_54","first-page":"4904","article-title":"Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study","volume":"54","author":"F, Belch J.J.; B, Shaw; A, O.'Dowd","year":"1985","unstructured":"Belch J J F, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study. Thromb Haemost 1985; 54: 4904.","journal-title":"Thromb Haemost"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-9343(89)90261-1","article-title":"Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study","volume":"86","author":"A, DiGiacomo R.; M, Kremer J.; M, Shah D.","year":"1989","unstructured":"DiGiacomo R A, Kremer J M, Shah D M. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med 1989; 86: 158-64.","journal-title":"Am J Med"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0002-9343(89)80148-2","article-title":"International study of ketanserin in Raynaud's phenomenon","volume":"87","author":"Jay, D.; D, Coffman M.; L, Clement D.","year":"1989","unstructured":"Jay D, Coffman M D, Clement D L, et al. International study of ketanserin in Raynaud's phenomenon. Am J7 Med 1989; 87: 264-8.","journal-title":"Am J7 Med"},{"key":"ref_57","first-page":"521","article-title":"The treatment of Raynaud's syndrome by fibrinolytic enhancement","volume-title":"Progress in chemicalfibrinolysis and thrombolysis. Vol 3","author":"M, Jarrett P.E.; M, Morland; L, Browse N.","year":"1978","unstructured":"Jarrett P E M, Morland M, Browse N L. The treatment of Raynaud's syndrome by fibrinolytic enhancement. In: Davidson J F, Rowan R M, Samama M M, Desnoyers P C, eds. Progress in chemicalfibrinolysis and thrombolysis. Vol 3. New York: Raven Press, 1978: 521-8."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(82)90215-X","article-title":"Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease","volume":"i:","author":"G, Franks A.","year":"1982","unstructured":"Franks A G. Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease. Lancet 1982; i: 76-7.","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1988.tb03502.x","article-title":"The effects of topically applied hexyl nicotinate lotion on the cutaneous blood flow in patients with Raynaud's phenomenon","volume":"119","author":"B, Bunker C.; S, Lanigan; A, Rustin M.H.; M, Dowd P.","year":"1988","unstructured":"Bunker C B, Lanigan S, Rustin M H A, Dowd P M. The effects of topically applied hexyl nicotinate lotion on the cutaneous blood flow in patients with Raynaud's phenomenon. BrJ Dermatol 1988; 119: 771-6.","journal-title":"BrJ Dermatol"},{"key":"ref_60","first-page":"310","article-title":"Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon. BMJ'","volume":"284","author":"Miyazaki, S.; Miura, K.; Kasia, Y.; Abe, K.; Yoshinga, K.","year":"1982","unstructured":"Miyazaki S, Miura K, Kasia Y, Abe K, Yoshinga K. Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon. BMJ' 1982; 284: 310-1."},{"key":"ref_61","first-page":"757","article-title":"The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon","volume":"117","author":"A, Rustin M.H.; E, Almond N.; A, Beacham J.; P, Dowd","year":"1987","unstructured":"Rustin M H A, Almond N E, Beacham J A, Dowd P. The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon. BrJ Dermatol 1987; 117: 757-8.","journal-title":"BrJ Dermatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724104062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724104062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.50.Suppl_4.839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:21:40Z","timestamp":1737523300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724104062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11]]},"references-count":61,"alternative-id":["S0003496724104062"],"URL":"https:\/\/doi.org\/10.1136\/ard.50.suppl_4.839","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1991,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raynaud's phenomenon: its relevance to scleroderma.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.50.Suppl_4.839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1991 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}